Twist Bioscience (NASDAQ:TWST) Price Target Cut to $18.00

Twist Bioscience (NASDAQ:TWST – Get Rating) had its price target lowered by analysts at Robert W. Baird from $29.00 to $18.00 in a research report issued on Monday, The Fly reports. Robert W. Baird’s target price would suggest a potential upside of 33.14% from the stock’s current price. Several other equities analysts have also recently […]

Related Keywords

Canada ,Robertw Baird , ,First Horizon Advisors Inc ,Barclays ,Twist Bioscience Corp ,Goldman Sachs Group ,Lazard Asset Management ,Twist Bioscience ,Get Rating ,Financial Advisors ,Horizon Advisors ,Pension Plan Investment Board ,Asset Management ,Sandia Investment Management ,Next Generation Sequencing ,Twist Bioscience Daily ,Nasdaq Twst ,Twst ,Medical ,Lower Price Target ,